GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC, TERT |
8.47859 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FUT7, HSD17B1, MET, PPARA |
7.30662 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, PIM1, PPARA, PTAFR, XDH |
7.28922 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.23777 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
6.91289 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
6.91289 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B1, KDR, MET, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, XDH |
6.91289 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.12431 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PPARA, PTAFR, SRC, TERT |
6.03163 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS2, TOP2A |
6.01663 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.7921 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP2, PPARA, PTAFR, SRC |
5.64172 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.64172 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.64172 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, PPARA |
5.64172 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.64172 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTAFR, SRC |
5.5404 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTAFR, SRC, TERT |
5.47793 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
5.35552 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
5.22697 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, PTAFR |
5.15292 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.0935 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PTAFR, SRC, TERT, TNKS, TNKS2, XDH |
5.0935 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA3, ALOX15, APEX1, APP, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTAFR, SRC, TERT |
5.0308 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
5.00989 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.98354 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, APP, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTAFR, SRC, TERT, XDH |
4.93736 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, IGF1R, MMP2, MMP9, PPARA, PTAFR, SRC |
4.93736 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TERT, TOP2A, XDH |
4.93736 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.92625 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
4.90412 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.7729 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.72888 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, IGF1R, KDR, MET, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
4.70863 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTAFR, TERT |
4.60568 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
4.55245 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CYP1A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, PTAFR, SRC |
4.5215 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTAFR, SRC, TERT, TOP2A |
4.49715 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
4.41055 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, PPARA, PTAFR, SRC |
4.25547 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
4.24853 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TERT |
4.24853 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, TERT |
4.20351 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.1144 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, IGF1R, KDR, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
4.09868 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.08241 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1 |
4.05947 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1 |
3.9907 |
[BP] GO:0042592 |
homeostatic process
|
ADRB1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.96494 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, KDR, PPARA, PTPRS, SRC |
3.96012 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.96012 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.9451 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SRC, TNKS, XDH |
3.9451 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MET, MMP9, PIM1, SRC, TERT |
3.94344 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, PTAFR, SRC |
3.92544 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.91735 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, PTAFR, SRC |
3.88965 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTAFR, TERT |
3.88965 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, EGFR, ERBB2, PPARA |
3.85233 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, GLO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.85233 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, GLO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.74853 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SRC, TNKS, XDH |
3.71674 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
3.71674 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, PTAFR, SRC |
3.67477 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.66411 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.66411 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
3.53719 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTAFR, TERT |
3.52963 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
3.52441 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, SRC, XDH |
3.48573 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.42056 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MMP9, PIM1, SRC, TERT |
3.29692 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.29692 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTAFR, SRC, TERT, TOP2A |
3.26481 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.25723 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, FABP4, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, SRC, TNKS2 |
3.23845 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, PTAFR, SRC |
3.21748 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.21748 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, MMP2, MMP9, PPARA, PTAFR, SRC, TERT, TOP2A |
3.21748 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, AURKB, EGFR, ERBB2, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A |
3.21748 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC, TNKS, TOP2A |
3.21748 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP9, SRC, XDH |
3.19284 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.16585 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.15248 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, MMP9, SRC |
3.15156 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.15156 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, XDH |
3.15156 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.13871 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, MMP12, MMP9, PPARA, PTAFR, SRC, TERT |
3.09696 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.09696 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, EGFR, FLT3, PTAFR, SRC |
3.09696 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, IGF1R, MMP2, MMP9, PTAFR, SRC |
3.08976 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, CA2, CA7, CACNA1C, EGFR, KDR, SRC, TNKS, TNKS2 |
3.07702 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, PTAFR, SRC |
3.05906 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA |
3.05504 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
2.99334 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
2.97826 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.92731 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.89431 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, APP, AXL, CA2, CYP19A1, EGFR, ERBB2, MMP12, PTAFR, SRC, TERT |
2.88729 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, APP, AXL, CBR1, CYP1A1, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, KDR, MET, MMP2, MMP9, PTPRS, SRC, TERT, TOP2A |
2.8856 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.87903 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, PTAFR, SRC |
2.85943 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.85904 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, EGFR, ERBB2, FLT3, MET, PIM1, SRC |
2.85904 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.852 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS |
2.80773 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, PTAFR, SRC |
2.80773 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.80773 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, MMP2, PTAFR, SRC |
2.80472 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRB1, ALOX15, APP, AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.80472 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.79979 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.79979 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.78715 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.78715 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.78368 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, APP, AURKB, EGFR, ERBB2, FABP3, IGF1R, MET, MMP12, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A |
2.78233 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADRB1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, MMP2, PPARA, PTAFR, SRC, TERT |
2.77098 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, MET |
2.75991 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, EGFR, ERBB2, FLT3, IGF1R, MMP2, PTAFR, SRC |
2.74581 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.74357 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.7388 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, PTAFR |
2.69792 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.65171 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRB1, ALOX15, APP, AURKB, CSNK2A1, EGFR, ERBB2, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.62948 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, MMP2, PTAFR, SRC |
2.607 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.607 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRB1, ALOX15, APP, AURKB, EGFR, ERBB2, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.607 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.607 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.60071 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.58085 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.55449 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, EGFR, ERBB2, IGF1R, KDR, MET, MMP12, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A |
2.54512 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, SRC, XDH |
2.54512 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.54512 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.54512 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.53935 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, SRC, TNKS, TNKS2 |
2.53029 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CYP19A1, EGFR, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPRS, SRC, TERT, XDH |
2.53025 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, KDR, MMP2, PTAFR, SRC |
2.51352 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.51352 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, ADRB1, APP, AXL, CA2, CACNA1C, CYP1B1, EGFR, ERBB2, KDR, MET, MMP12, MMP9, PIM1, PTAFR, PTPRS, SRC, TERT, TNKS2, XDH |
2.47977 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.4746 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.46089 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.45293 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FLT3, KDR, MMP9, PTAFR, SRC, XDH |
2.45232 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FLT3, KDR, MMP9, PTAFR, SRC, XDH |
2.45232 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTAFR, SRC, TNKS, TNKS2 |
2.4228 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, TNKS, TNKS2 |
2.41835 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41835 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.40349 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.38501 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.38249 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTAFR, SRC, XDH |
2.38249 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.38249 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38249 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.36625 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, APP, AXL, CA2, CYP1B1, EGFR, KDR, MET, MMP12, MMP9, PIM1, PTAFR, SRC, TERT |
2.35935 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTAFR, SRC, XDH |
2.3547 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
2.3547 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, SRC |
2.3547 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, APP, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, KDR, MMP9, PIM1, PPARA, PTPRS, SRC |
2.33802 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.33466 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.33466 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.33466 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33466 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.32095 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.30871 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.26274 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.26274 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.26274 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, EGFR, FABP3, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, XDH |
2.24829 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, SRC |
2.24668 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, ERBB2, PPARA |
2.24668 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, FUT7, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TNKS, TNKS2, TOP2A, XDH |
2.23325 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.22879 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CYP1A1, EGFR, SRC, TERT |
2.22745 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, CYP1A1, EGFR, PIM1, TERT, TNKS, TOP2A |
2.21897 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, HSD17B1 |
2.21825 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.21521 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, EGFR, ERBB2, FLT3, KDR, SRC, XDH |
2.21033 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.17666 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.1639 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, CA2, CA7, PTAFR |
2.15977 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.15536 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, PTAFR, SRC |
2.14153 |
[BP] GO:1901989 |
None
|
APEX1, APP, CYP1A1, TERT |
2.12475 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.12475 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, IGF1R, KDR, MET, MMP1, MMP9, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.12332 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.1217 |
[BP] GO:0030177 |
positive regulation of Wnt signaling pathway
|
CSNK2A1, SRC, TERT, TNKS, TNKS2 |
2.11429 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.10255 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.10202 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA |
2.10193 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, ERBB2, KDR, SRC |
2.07303 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, KDR, SRC |
2.05185 |
[BP] GO:0032212 |
positive regulation of telomere maintenance via telomerase
|
AURKB, TNKS, TNKS2 |
2.02055 |
[BP] GO:1903961 |
None
|
ABCB1, PTAFR |
2.0174 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.0174 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.00855 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, PPARA, SRC, TOP2A |
2.00582 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA3, ADRB1, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, FLT3, GLO1, IGF1R, KDR, MET, MMP2, PIM1, PTAFR, PTPRS, SRC, TERT |
2.97228 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA3, ADRB1, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PTAFR, PTPRS, SRC |
2.38249 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, KDR, MMP2, MMP9, PIM1, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.34691 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, APP, CA4, EGFR, ERBB2, SRC, TNKS2 |
2.26492 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA3, ADRB1, ALOX15, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, FUT7, GLO1, IGF1R, KDR, MET, MMP2, PIM1, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2 |
2.04984 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADRB1, AKR1B1, AKR1B10, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
2.00855 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
12.2645 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
10.9352 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.5098 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TNKS, XDH |
10.251 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.23777 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.68332 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
6.33727 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.7921 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.73683 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TERT, TNKS, TNKS2, TOP2A, XDH |
4.93736 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.85479 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
4.65158 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TERT, TNKS, TNKS2, TOP2A, XDH |
4.57092 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, TNKS |
4.20351 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
4.08241 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.91861 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, XDH |
3.91861 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.73751 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SRC, TOP2A, TUBB3, XDH |
3.73751 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
3.57474 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.43691 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.94926 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.93786 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SRC |
2.80773 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TERT |
2.74538 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.68271 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.51113 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SRC, TOP2A, TUBB3 |
2.41835 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, XDH |
2.41187 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.38625 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.37192 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, APEX1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, SRC |
2.32795 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R |
2.11429 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.10591 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.10531 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0174 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP2A |
2.00855 |